Leukemia Inhibitory Factor Receptor Alpha (LIFRα), also known as CD118, is a crucial component of the cytokine receptor family. It plays a significant role in mediating the biological effects of various cytokines, including Leukemia Inhibitory Factor (LIF), Cardiotrophin-1, and Oncostatin M . This receptor is essential for numerous physiological processes, including cell differentiation, proliferation, and survival.
LIFRα is a type I transmembrane protein with a molecular weight of approximately 190 kDa . It forms a high-affinity receptor complex with gp130, a common signal transducing subunit shared by all members of the IL-6 cytokine family . This complex is responsible for activating downstream signaling pathways, such as the JAK/STAT and MAPK cascades .
LIFRα is expressed in various tissues throughout the body, including the trophectoderm of the developing embryo . Its expression is crucial for the maintenance of pluripotency in embryonic stem cells, as it promotes self-renewal by recruiting signal transducer and activator of transcription 3 (Stat3) .
LIFRα mediates the effects of LIF, which is known for its ability to induce the terminal differentiation of myeloid leukemic cells . This receptor is involved in several physiological processes, including: